Press release
Impact Of Increasing Cancer And Cardiovascular Disease Prevalence On The Growth Of The Generic Injectable Market: A Key Catalyst Accelerating Generic Injectables Market Growth in 2025
Generic Injectables Market
Generic Injectables Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the last few years, the market size for generic injectables has witnessed significant growth. The market, which stands at $124.61 billion in 2024, is predicted to rise to $143.13 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 14.9%. Factors contributing to this increase during the historic period include its cost-effectiveness, patent expirations, initiatives to expand healthcare access, market competition, and worldwide trends in the pharmaceutical industry.
Generic Injectables Market Size Forecast: What's the Projected Valuation by 2029?
The size of the generic injectables market is anticipated to experience a swift expansion in the coming years, projected to reach "$238.43 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. Factors contributing to the growth during the forecast period include a rise in the elderly population, regulatory adjustments, strategic collaborations, heightened awareness of health concerns, and innovative strides in the market. Major trends anticipated during this period involve focus on standard and regulatory compliance, adoption of the 505 (b) (2) regulatory pathway, the creation of innovative drug delivery methods, industry collaborations and partnerships, and an amplified emphasis on specialty injectable treatments.
View the full report here:
https://www.thebusinessresearchcompany.com/report/generic-injectables-global-market-report
What Are the Drivers Transforming the Generic Injectables Market?
The escalating occurrence of cancer and cardiovascular ailments is set to spur the expansion of the generic injectable market in the future. A variety of heart and blood vessel disorders are grouped under cardiovascular diseases, while cancer refers to a condition where the body's cells grow without restraint and infiltrate other body parts. Generic injectables, mirroring the pharmaceutical equivalence or bioequivalence of branded drugs, are essential in treating cancer and heart diseases. They improve drug availability and accessibility, rendering treatments more affordable. For instance, the World Health Organization reported in September 2022 that 41 million deaths, 74% of which are due to non-communicable or chronic diseases, occur annually worldwide. These deaths include 17.9 million from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, the mounting occurrence of cancer and cardiovascular ailments is fueling the growth of the generic injectable market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10776&type=smp
What Long-Term Trends Will Define the Future of the Generic Injectables Market?
Product innovation continues to shape the generic injectables market. In April 2022, India-based Dr. Reddy's Laboratories released Treprostinil Injection in the US market, a generic version of Remodulin approved by the USFDA, supporting patients transitioning from epoprostenol for improved clinical outcomes.
Which Segments in the Generic Injectables Market Offer the Most Profit Potential?
The generic injectables market covered in this report is segmented -
1) By Product Type: Monoclonal Antibodies, Cytokines, Insulin, Vaccines, Other Products
2) By Container Type: Vials, Ampoules, Premix, Prefilled Syringes, Other Containers
3) By Route Of Administration: Intravenous, Intramuscular, Subcutaneous, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Stores, Online Prescription Stores
5) By Application: Oncology, Diabetes , Infectious Diseases , Blood Disorders , Musculoskeletal Disorders , Hormonal Disorders , Pain Management , CNS Diseases , Cardiovascular Diseases
Subsegments:
1) By Monoclonal Antibodies: IgG Monoclonal Antibodies, IgM Monoclonal Antibodies, Other Types Of Monoclonal Antibodies
2) By Cytokines: Interferons, Interleukins, Tumor Necrosis Factor (TNF) Inhibitors
3) By Insulin: Rapid-Acting Insulin, Long-Acting Insulin, Combination Insulin
4) By Vaccines: Inactivated Vaccines, Live Attenuated Vaccines, Recombinant Vaccines
5) By Other Products: Hormones, Peptides, Enzymes
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10776&type=smp
Which Firms Dominate the Generic Injectables Market by Market Share and Revenue in 2025?
Major companies operating in the generic injectables market include Baxter International Inc., Sanofi SA, AstraZeneca plc., Fresenius Medical Care AG & Co. KGaA, Johnson & Johnson, Merck & Co. Inc., Biocon Limited, Lupin Limited, Dr. Reddy's Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Cipla Limited, Aurobindo Pharma Limited, Samsung Biologics Co. Ltd., Piramal Pharma Limited, Bristol-Myers Squibb Company, Pfizer Inc., Hikma Pharmaceuticals PLC, Par Pharmaceutical, Pharmascience Inc., SAGENT Pharmaceuticals, AmerisourceBergen Corporation, Hospira Inc., Sandoz International GmbH, Singota Solutions Inc., MVASI Bevacizumab-awwb Syringes, Mylan N.V., Sun Pharmaceutical Industries Ltd., Endo International plc, Akorn Pharmaceuticals Inc., Wockhardt Limited
Which Regions Offer the Highest Growth Potential in the Generic Injectables Market?
North America was the largest region in the generic injectable market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generic injectables market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10776
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Impact Of Increasing Cancer And Cardiovascular Disease Prevalence On The Growth Of The Generic Injectable Market: A Key Catalyst Accelerating Generic Injectables Market Growth in 2025 here
News-ID: 4106530 • Views: …
More Releases from The Business Research Company
Guidewires Market Expansion Continues, with Forecast Valuation of $3.38 Billion …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Guidewires Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of guidewires has seen substantial growth in the recent past. The market, which was worth $2.48 billion in 2024, is projected to rise to $2.62 billion in 2025, exhibiting a compound annual growth…
Future of the Food Decorations and Inclusions Market: Strategic Analysis and For …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Food Decorations and Inclusions Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of food decorations and inclusions has seen robust expansion over the past few years. From a value of $9.21 billion in 2024, it is projected to increase to $9.87 billion…
Surge In Vegetable Production To Drive Market Growth: Critical Driver Shaping th …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Fertigation & Chemigation Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size of fertigation and chemigation has seen substantial growth in the past few years. It is projected to expand from $45.69 billion in 2024 to $49.02 billion in 2025, with a compound…
Emerging Trends to Reshape the Exosome Technologies Market: Creative Biolabs Lau …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Exosome Technologies Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In the past few years, the exosome technologies market size has seen a significant exponential growth. The market is projected to expand from $0.07 billion in 2024 to $0.09 billion in 2025, with a compound…
More Releases for Generic
Generic Injectables Market growth is attributed to the increasing demand for Onc …
According to Precision Business Insights (PBI), the latest report, the generic injectables market will be worth USD 22.0 billion in 2022, growing at an 11.0% CAGR from 2022 to 2028. The global generic injectables market is segmented into the following types: Product Type (Monoclonal Antibodies, Cytokines, Insulin, Peptide Hormones, Blood Factors, Immunoglobulins, Peptide Antibiotics, Vaccines, and Others), Indication (Diabetes, Cancer, Cardiovascular Diseases, Musculoskeletal, CNS, Infections, and Others), Distribution Channel (Hospital…
A Demand On Generic Drugs Market And The Need To Push The Market Of Generic Drug …
Global Generic Drugs Market
A generic drug is pharmaceutical drug, which is bio-equivalent to a branded drug in all forms such as route of administration, strength, dosage, quality, intended use and performance. Generic drugs are usually approved after patent expiration of patent drugs. Generic drugs are safe, effective and FDA approved. The global market is filled with 44% of generic drugs.
The global generic drugs market is driven by the rise of…
Generic Wellness Offers Special Discount on Generic Xenical for Fat Reduction !
This week a special offer is introduced by Generic Wellness for weight loss treatment with an oral drug called generic Xenical. The drug is an excellent weight loss treatment for all men and women above the age of 12. People who have taken this drug for weight loss have actually experienced the benefits like reduction of unwanted fat in the body.
This is possible with generic Xenical because of the…
Generic Drugs Market Trends 2025
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017…
Generic Drugs Market - Global Competitive Analysis
Generic drugs market growth is buoyed by increasing number of expiries of patented drugs each year. According to the IMS data small-molecule products worth US$ 121 Bn are expected to lose patents in developed markets, such as U.S ad Europe between 2014 and 2018. The IMS also forecasts that biologic products valued at US$ 48 Bn are expected to lose patent protection over the next three years i.e from 2017…
Generic Drug Market: Global Generic Drug Share to Reach USD 380.60 Billion by 20 …
Zion Market Research has published a new report titled “Generic Drug Market by Brand (Pure Generic and Branded Generic) for Central Nervous System (CNS), Cardiovascular, Dermatology, Oncology, Respiratory and Others Therapeutic Applications - Global Industry Perspective, Comprehensive Analysis and Forecast, 2015 – 2021”. According to the report, the global generic drug market accounted for around USD 200.20 billion in 2015 and is expected to reach approximately USD 380.60 billion by…
